Serum 25-hydroxyvitamin D concentrations in dogs with osteosarcoma do not differ from those of age- and weight-matched control dogs

Vet J. 2016 Nov:217:132-133. doi: 10.1016/j.tvjl.2016.10.005. Epub 2016 Oct 12.

Abstract

Vitamin D concentrations show an inverse correlation with incidence of certain tumors in people and dogs. Additionally, human osteosarcoma has been associated with dysregulation of vitamin D-dependent pathways. The study objective was to compare serum 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in 20 dogs with osteosarcoma to age- and weight-matched control dogs. We hypothesized that dogs with osteosarcoma would have lower serum 25-hydroxyvitamin D than control dogs. The mean 25-hydroxyvitamin D3 concentrations for dogs with osteosarcoma and matched-controls were 34.95 ng/mL and 33.85 ng/mL, respectively (P = 0.784). Based on these data, 25-hydroxyvitamin D insufficiency might not be important in the pathogenesis of canine osteosarcoma.

Keywords: Bone; Cancer; Canine; Osteosarcoma; Vitamin D.

MeSH terms

  • 25-Hydroxyvitamin D 2 / blood*
  • Age Factors
  • Animals
  • Body Weight
  • Bone Neoplasms / blood
  • Bone Neoplasms / etiology
  • Bone Neoplasms / veterinary*
  • Calcifediol / blood*
  • Case-Control Studies
  • Dog Diseases / blood
  • Dog Diseases / etiology*
  • Dogs
  • Osteosarcoma / blood
  • Osteosarcoma / etiology
  • Osteosarcoma / veterinary*
  • Vitamins / blood*

Substances

  • Vitamins
  • 25-Hydroxyvitamin D 2
  • Calcifediol